MYALEPT Trademark Information

NOVELION THERAPEUTICS INC.

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of lipoatrophy, lipodystrophy, and leptin deficiency

Perfect for these industries

Words that describe this mark

pharmaceutical   preparations       pharmaceutical   preparations   treatment   prevention   lipoatrophy     lipodystrophy     leptin   deficiency  

This is a brand page for the MYALEPT trademark by NOVELION THERAPEUTICS INC.  in VANCOUVER, , BC V6B 0M.

Write a review about a product or service associated with this MYALEPT trademark. Or, contact the owner NOVELION THERAPEUTICS INC. of the MYALEPT trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the MYALEPT trademark.

Status Update! On Thursday, October 1, 2020, status on the MYALEPT trademark changed to CONTINUED USE AND INCONTESTIBILITY ACCEPTED.

On Thursday, December 1, 2011, a U.S. federal trademark registration was filed for MYALEPT. The USPTO has given the MYALEPT trademark serial number of 85484675. The current federal status of this trademark filing is CONTINUED USE AND INCONTESTIBILITY ACCEPTED. The correspondent listed for MYALEPT is Todd Armstrong, Ph.D. of Clark+Elbing LLP, 101 Federal Street, 15th Floor, Boston MA 02110 . The MYALEPT trademark is filed in the category of Pharmaceutical Products . The description provided to the USPTO for MYALEPT is Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of lipoatrophy, lipodystrophy, and leptin deficiency.

Word mark: MYALEPT
Status/Status Date:
CONTINUED USE AND INCONTESTIBILITY ACCEPTED
10/1/2020
Serial Number: 85484675
Filing Date: 12/1/2011
Registration Number: 4589120
Registration Date: 8/19/2014
Goods and Services: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment and prevention of lipoatrophy, lipodystrophy, and leptin deficiency
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 5/15/2012
Last Applicant/Owner: NOVELION THERAPEUTICS INC.
VANCOUVER BC V6B 0M
Mark Drawing Code: Standard Character Mark
Design Search: (NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
Clark+Elbing LLP
101 Federal Street, 15th Floor
Boston MA 02110

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere: : 6/2/2014
First Use In Commerce: 6/2/2014

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia Network Law firms! You can register your trademark in 170+ countries in the world through Trademarkia Network Law firms.

Trademarkia-Network law firms can help you incorporate a business around your MYALEPT trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network law firm - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Starting $399/class + govt fees! Click here >>
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner.
Current Trademark Status:
10/1/2020
CONTINUED USE AND INCONTESTIBILITY ACCEPTED
Correspondent Search:

Todd Armstrong, Ph.D. is a correspondent of MYALEPT trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do: